Stonepine Capital Management, LLC

Q2 2026 13F-HR/A Holdings

Location
Bend, OR
Holdings as of
6/30/2026
Date filed
8/17/2026
Form type
13F-HR/A - RESTATEMENT
Num holdings
87
Total value ($000)
$177,261
Net value change ($000)
-72,461 (-29.0%)
New positions
18
Sold out positions
14
Turnover %
24.3%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/14/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ELOXX PHARMACEUTICALS INC 5,513 NEW
INDV 4,103 NEW
EOLS 3,806 52.6%
MSLE 3,160 561.3%
EDSA 3,034 1932.5%
CABA 2,717 2012.6%
NKTR 2,307 37.7%
KZIA 2,292 89.3%
XLO 1,625 300.9%
SPRB 1,555 NEW
Top Reduces (Value $000, Stocks/ETFs)
CAMP -6,128 -100.0%
TENX -5,990 -38.4%
VSTM -4,706 -26.9%
XOMA -2,180 -100.0%
SLGL -1,128 -51.2%
SRZN -961 -100.0%
HRTX -913 -81.4%
CBIO -841 -53.9%
IKT -804 -50.0%
ZVRA -764 -17.1%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 45,900 (25.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type